Come up with a name for your new list and we'll add to it:
Siamab Therapeutics raised a round of funding on November 08, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Siamab Therapeutics, formerly Sialix, is a biopharmaceutical company developing novel cancer immunotherapies. Siamab has developed a platform of technologies that enable the rapid discovery and develo…